UnitedHealthcare
Benlysta (belimumab)
Drugs for Pain and Fever : Arthritis and Pain Drugs
  • Prior Authorization: Lupus Nephritis:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Systemic Lupus Erythematosus (SLE):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Lupus Nephritis:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Systemic Lupus Erythematosus (SLE):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Positive Autoantibody Test Required: Unspecified
    SELENA-SLEDAI Score Required: N/A
    Reauthorization SELENA-SLEDAI Score Required: N/A
    Patient Exclusion Criteria Documented in Policy: Combination therapy with Lupkynis or Saphnelo
    Reauthorization Requirements Documented in Policy: 2 of Adherence to product and standard of care therapy;Shows positive clinical response
    Does Policy Include Excluded Indications: Yes
    Supporting Documentation Requirements: Medical Tests

  • Step Therapy: ST Single Generic